Chris Roush

​BioCrust Pharmaceuticals, a Durham-based drug company, saw its stock fall by nearly 10 percent on Monday after it reported a loss and revenue in the second quarter that both missed Wall Street expectations. BioCryst reported a net loss of $16.9 million, or 21 cents per share, worse than the net loss of $16.3 million, or 22 cents per share, in the same quarter a year ago. Analysts were expecting a loss of 19 cents per share. The company’s revenue for the quarter was $3.1 million, down from the $4.8 million in the second quarter of 2016 and below the...

Three N.C. technology and life science firms report financials that are at least positive in one respect: RTP-based TransEnterix reports revenue higher than expectations Qorvo’s earnings beat, but projects future results below expectations High Point-based VTV Therapeutics beats analyst earnings estimate Chris Roush, editor of North Carolina Business News Wire, reports: RTP-based TransEnterix reports revenue higher than expectations RESEARCH TRIANGLE PARK – Medical device company TransEnterix Inc. reported second-quarter revenue above analyst expectations and a net loss that met Wall Street projections, according to a filing Wednesday with the Securities and Exchange Commission. The Research Triangle Park-based company reported...

A well-known investor in biotech companies has purchased a 6.8 percent stake in Durham-based Dova Pharmaceuticals Inc., according to a filing Tuesday with the Securities and Exchange Commission. Joseph Edelman of Perceptive Advisors LLC purchased 1.7 million shares of the company, worth more than $30 million. Edelman founded New York-based Perceptive Advisors in 1999. Previously, he was senior analyst at Aries Fund, a Paramount Capital Asset Management biotechnology hedge fund, from November 1994 through December 1998. Before that, Edelman was senior biotechnology analyst at Prudential Securities for four years. He started his career in the health care sector of...

A Cleveland-based company that builds motion and control technologies plans to close its plant in Washington, North Carolina, and lay off 220 workers, according to a filing with the North Carolina Department of Commerce. Parker Hannifin Corp. filed the WARN Act notice earlier this week. The filing states that the layoffs would begin on Sept. 7 and would be completed by Dec. 31. The employees being affected are not part of a union. According to the filing, more than 130 of the employees losing jobs are assemblers. The plant is in the eastern part of North Carolina. The 175,000-square-foot...

HIGH POINT—HIGH POINT, N.C. — A High Point-based drug development company has been threatened with having its stock being delisted by Nasdaq because its market capitalization does not exceed $50 million, according to a filing with the Securities and Exchange Commission. VTV Therapeutics received the notice from the stock exchange on June 27 and has until Dec. 26 to comply with the regulation. The company notes that if its Class B shares were all converted to Class A shares, it would have a market capitalization in excess of $150 million. VTV has a pipeline of small molecule clinical and...

A Mooresville, NC company that has developed a unique sleeping system has raised $1.3 million in a private equity offering, according to a filing with the Securities and Exchange Commission. Kryo Inc. raised the money from four investors, according to the filing. It seeks an additional $1.2 million in the round. The Mooresville-based company was founded by Todd Youngblood, co-founder of Chili Technology and the well-known ChiliPad, and his wife Tara Youngblood. Mooresville is located in Southern Iredell County about 25 miles north of Charlotte. The Kryo Sleep Performance System uses each individual’s sleep data to optimize sleep through temperature management....